Recently, the antitumorigenic role of mannose-binding lectin (MBL) was proposed since there was a significantly higher frequency of mbl2 genotypes associated with MBL deficiency/insufficiency in ovarian cancer patients than in the age-matched control group [8]. Here, MBL2 is linked to hyperinsulinemic hypoglycemia, familial, 4.